cash was increased by 8 million dollars to 179 million or 3.37 per diluted share.
Book value stands at 4.37 per share.
3Q10 revenue increases 30% to US$68.6 million compared to 3Q09
revenue is now on a 300 million dollar run rate.
eps was .09 cts. 2011 estimates will be .55-.65cts
The shares should trade to five in the days ahead. (JMHO!)
Yeeeehaaaaah!!! :)
Gruss
$pooky
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM